BON BON NAT LIFE LTD

Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder Drinks

Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder Drinks

XI'AN, China, June 02, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the launch of three powder drinks to its cruciferous vegetable-based health supplement series. The new powder drinks include: broccoli seed caffeine powder drink, broccoli seed coconut powder drink, and broccoli seed green tea powder drink.

Thoughtfully formulated, the combination of broccoli seed extract and BON’s proprietary prebiotic stachyose can help regulate microbiome health to improve one’s immune system and overall health.

“We are thrilled to expand the line of our cruciferous vegetable-based supplement series with the announcement of the new powder drinks.” Commented Mr. Richard (Yongwei) Hu, CEO and Chairman of BON, “This marks another important step in our expansion into the consumer market. According to the research by Daxue Consulting, health-awareness is growing and influencing the beverage industry in China. Leveraging our technology and experience, BON’s three new powder drinks are able to create a comprehensive product suite to the health-conscious young consumers. We are optimistic about the market opportunity and the potential revenue growth from our nutraceutical powder drinks.”

About Bon Natural Life Limited

The Company focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds for perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by their customers. For additional information, please visit the Company’s website at .

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the natural, health and personal care market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at . The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

In the United States: 
Maggie Zhang | Impact IRSophie Zhang | Impact IR
Email:  Email: 



EN
02/06/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BON NAT LIFE LTD

 PRESS RELEASE

Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notific...

Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, 2025, the Company received a letter (the “Notification Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”), notifying the Company that it was not in compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid...

 PRESS RELEASE

BON Announces Apple Polyphenol Commercial Order Signed

BON Announces Apple Polyphenol Commercial Order Signed XI'AN, China, April 11, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a groundbreaking 24-month supply agreement worth $12M with Shanghai Yunsheng, China's premier functional ingredients distributor, to co-develop next-generation apple polyphenol-infused health solutions. The partnership leverages BON's patented extraction technology to deliver science-backed formulations combining antioxi...

 PRESS RELEASE

BON Announces Unlocking Broccoli's Nutritional Power: Advanced Deliver...

BON Announces Unlocking Broccoli's Nutritional Power: Advanced Delivery System for Glucoraphanin Activation XI’AN, China, April 08, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced our biotech innovation addresses nutritional critical challenges through a patent-pending Glucoraphanin-Myrosinase co-delivery system that significantly enhances the bio-activity of glucoraph anin, a key bio-active compound in broccoli. Broccoli stands as a nutrient-r...

 PRESS RELEASE

BON Announces Breakthrough in the Bio-manufacturing Technology of Tea ...

BON Announces Breakthrough in the Bio-manufacturing Technology of Tea Pigments XI’AN, China, April 07, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced between October 2024 to January 2025, our company achieved groundbreaking progress in the bio-manufacturing technology of tea pigments, attaining an industrial-leading yields rate of 12-16% while maintaining purity levels surpassing 95%. Demonstrating significant biological properties inc...

 PRESS RELEASE

BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Pate...

BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch XI’AN, China, March 20, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar is gearing up for release. The Company has engineered a food-derived postbiotic formula for glycemic management, slated to hit shelves in the near term. When taken 10-30 minutes before meals, this breakthr...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch